120 related articles for article (PubMed ID: 4831715)
1. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
Henschel V; Jaminet F
J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
[No Abstract] [Full Text] [Related]
2. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
Worthington HE
Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
[No Abstract] [Full Text] [Related]
4. Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs.
Bagatell FK; Augustine MA
Curr Ther Res Clin Exp; 1974 Jul; 16(7):748-57. PubMed ID: 4210465
[No Abstract] [Full Text] [Related]
5. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
Meyer E; Smith EW; Haigh JM; Kanfer I
Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
[TBL] [Abstract][Full Text] [Related]
6. [Comparative testing of a new cream-base against unguentum diachylon in ulcus cruris].
Klostermann GF; Jakob H
MMW Munch Med Wochenschr; 1974 Jun; 116(23):1169-70. PubMed ID: 4212590
[No Abstract] [Full Text] [Related]
7. [Penetration kinetics of topical steroids].
Tronnier H
Arch Klin Exp Dermatol; 1970; 237(3):769-73. PubMed ID: 5523569
[No Abstract] [Full Text] [Related]
8. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
Snyder DS; Greenberg RA
J Invest Dermatol; 1974 Dec; 63(6):461-3. PubMed ID: 4430856
[No Abstract] [Full Text] [Related]
9. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
Woodford R; Barry BW
Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
[No Abstract] [Full Text] [Related]
10. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
Koch EM; Jurgovsky E
Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
[TBL] [Abstract][Full Text] [Related]
11. Animal studies with topical steroids.
Weidmann H
Acta Derm Venereol Suppl (Stockh); 1973; 53():25-7. PubMed ID: 4518659
[No Abstract] [Full Text] [Related]
12. [Comparison of the efficiency of various externally used corticosteroids].
Horácek J; Semrádová V
Z Hautkr; 1974 Jul; 49(13):555-8. PubMed ID: 4423320
[No Abstract] [Full Text] [Related]
13. Effect of short-term administration of synthetic corticosteroids on pituitary-adrenal function.
Fotherby K; Warren RJ; Harcus AW
Arzneimittelforschung; 1974 Jan; 24(1):97-9. PubMed ID: 4406120
[No Abstract] [Full Text] [Related]
14. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
Weirich EG; Lutz U
Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
[No Abstract] [Full Text] [Related]
15. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
[TBL] [Abstract][Full Text] [Related]
16. Influence of corticosteroid on recovery from oxygen toxicity.
Sahebjami H; Gacad G; Massaro D
Am Rev Respir Dis; 1974 Nov; 110(5):566-71. PubMed ID: 4429252
[No Abstract] [Full Text] [Related]
17. Plethysmographic recordings of skin pulses. IV. The vasoconstrictive effect of steroids in normal and stripped skin.
Thune P
Acta Derm Venereol; 1971; 51(4):261-7. PubMed ID: 4105772
[No Abstract] [Full Text] [Related]
18. Vasoconstrictor and systemic activities of topical steroids.
Burdick KH; Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
Arch Dermatol; 1968 Dec; 98(6):684-6. PubMed ID: 5697255
[No Abstract] [Full Text] [Related]
19. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
Gregurek-Novak T
J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):81-2. PubMed ID: 11451336
[No Abstract] [Full Text] [Related]
20. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
Altmeyer P; Zaun H
Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
